Dynamic permeability and quantitative susceptibility related imaging biomarkers in cerebral cavernous malformations

Stroke

Volumn 45, Issue 2, 2014, Pages 598-601

  Mikati, Abdul Ghani ^a   Tan, Huan ^a   Shenkar, Robert ^a   Li, Luying ^a,b   Zhang, Lingjiao ^a   Guo, Xiaodong ^a   Larsson, Henrik B W ^h,i   Shi, Changbin ^a   Liu, Tian ^c   Wang, Yi ^d,e   Shah, Akash ^a   Edelman, Robert R ^f,g   Christoforidis, Gregory ^a   Awad, Issam ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SICHUAN UNIVERSITY   (China)

^c Medimagemetric LLC   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e School of Operations Research and Industrial Engineering   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

ⁱ NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Biomarkers; Cerebral cavernous malformations; Cerebrovascular disorders; Hemangioma, cavernous; Hemorrhagic stroke; Magnetic resonance imaging; Vascular permeability

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADODIAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; BRAIN MAPPING; CAVERNOUS HEMANGIOMA; CHILD; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE ACTIVITY; DISEASE MARKER; DYNAMIC CONTRAST ENHANCED QUANTITATIVE PERFUSION; DYNAMIC PERMEABILITY; FEMALE; HEMODYNAMICS; HUMAN; IRON STORAGE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY; SCHOOL CHILD; TREATMENT RESPONSE;

BIOMARKERS; CEREBRAL CAVERNOUS MALFORMATIONS; CEREBROVASCULAR DISORDERS; HEMANGIOMA, CAVERNOUS; HEMORRHAGIC STROKE; MAGNETIC RESONANCE IMAGING; VASCULAR PERMEABILITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN MAPPING; CAPILLARY PERMEABILITY; CHILD; CONTRAST MEDIA; DATA INTERPRETATION, STATISTICAL; FEMALE; GADOLINIUM; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; YOUNG ADULT;

EID: 84893721682     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003548     Document Type: Article

References (14)

1. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71:188-192.
2. Wong JH, Awad IA, Kim JH. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000;46:1454-1459.
3. Tu J, Stoodley MA, Morgan MK, Storer KP. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg. 2005;103:903-909.
4. McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43:571-574.
5. Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010;207:881-896.
6. Larsson HBW, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn Reson Med. 2009;62:1270-1281.
7. Hoffmann A, Bredno J, Wendland MF, Derugin N, Hom J, Schuster T, et al. Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology. Stroke. 2011;42:2054-2060.
8. Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, Gupta SN, et al. Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia. 2007;9:546-555.
9. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2010;63:194-206.
10. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage. 2011;54:2789-2807.
11. Liu T, Liu J, Rochefort Ld, Spincemaille P, Khalidov I, Ledoux JR, et al. Morphology enables dipole inversion (MEDI) from a single-angle acquisition: comparison with cosmos in human brain imaging. Magn Reson Med. 2011;66:777-783.
12. Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, Tsiouris AJ, et al. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011;24:1129-1136.
13. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15:177-184.
14. Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009;119:131-138.